Literature DB >> 2951607

IgA nephropathy: association of a history of macroscopic hematuria episodes with increased production of polymeric IgA.

L Lozano, R García-Hoyo, J Egido.   

Abstract

From the clinical point of view patients with IgA nephropathy present two main symptoms. Some patients have episodes of macroscopic hematuria, either isolated or recurrent, while others present only asymptomatic urinary abnormalities. Although these differences could be due to age-related, geographical or other unknown reasons, in this paper we studied whether patients with these two clinical manifestations differ in some IgA immunological aspects, described occasionally as abnormal in this disease. The following results were obtained: patients having a history of macroscopic hematuria episodes (n = 29) had a significant increase in the percentage of blood polymeric-IgA-producing cells (68 +/- 12%) and in the T cells with IgA Fc-receptors (T alpha cells; 14.5 +/- 3%) in relation to those having only asymptomatic urinary abnormalities (n = 13; 48 +/- 11 and 11.8 +/- 3%, respectively). However, there was no difference in the two groups of patients in relation to the serum IgA levels, percentage of IgA-bearing cells, in vitro synthesis of IgA, T-cell subpopulation and generation of Con A-IgA suppressor cells. Since these patients did not differ in the age of the apparent onset of the disease, in age at the moment of the study or in the activity of the disease determined by hematuria, our results afford an immunological support suggesting the existence of two subgroups of patients with IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2951607     DOI: 10.1159/000184087

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy.

Authors:  L Layward; A C Allen; S J Harper; J M Hattersley; J Feehally
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

2.  Systemic immune response after mucosal immunization in patients with IgA nephropathy.

Authors:  F B Waldo
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

3.  Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy.

Authors:  A W van den Wall Bake; M R Daha; A van der Ark; P S Hiemstra; J Radl; L A van Es
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

4.  Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy.

Authors:  Guanhong Li; Xiaoyan Wang; Zhe Yang; Qing Zhao; Yubing Wen; Xuemei Li; Ruitong Gao
Journal:  Dis Markers       Date:  2019-07-02       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.